RegulatorsFDAUnited States
FDA Public Notification: Tawon Liar Contains Hidden Drug Ingredients
Regulatory action
Public Notification
Tawon Liar
Relevant for
Regulatory Intelligence LeadSignal Management Lead
Action needed
Review product inventory for Tawon Liar; report any adverse events to FDA MedWatch; consider adding product to signal monitoring list; ensure labeling compliance checks for similar products.
Process impact
Signal ManagementLabeling
SOP impact
2 SOPs may need review
Urgency: HighConfidence: high
Read impact brief →